Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572481 · ClinicalTrials.gov registry record · Phase 2
Axillary Reverse Mapping
A Phase 2 study of Cancer of the Breast, sponsored by University of Arkansas.
- Active
- Registry status
- Phase 2
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT00572481: Active Phase 2 study of Cancer of the Breast, sponsored by University of Arkansas.
NCT00572481 is a Phase 2 study of Cancer of the Breast that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 1,000 participants, above the 114-participant average among 15 other Cancer of the Breast trials with a reported enrollment target (777% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572481, a Phase 2 study of Cancer of the Breast, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
We hypothesize that variations in anatomic location of the arm lymphatic drainage system put the arm lymphatics at risk for disruption during a SLNB and / or ALND. Therefore, mapping the drainage of the arm during the procedure would decrease the likelihood of inadvertent disruption of the lymphatics and the subsequent development of lymphedema. A combination of radioactivity and blue dye will be used.
Primary Outcome
An occurrence will consist of an increase of 20% or more in ipsilateral arm volume over the pre-surgery volume, and be accompanied by a confirmatory diagnosis of lymphedema from the UAMS lymphedema clinic.
Conditions Studied
Interventions
- PROCEDURE Axillary Reverse Mapping
Study Locations (1)
Arkansas
- University of Arkansas For Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-05 |
| Est. Completion | 2027-11 |
| Phase | Phase 2 |
What the registry record for NCT00572481 still lists
NCT00572481 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 114-participant average among 15 other Cancer of the Breast trials with a reported enrollment target (777% higher).
The record links to 1 condition, with Cancer of the Breast appearing as the primary indexed condition, and to 1 intervention - of which Axillary Reverse Mapping is the first listed.
NCT00572481 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00572481 about?
NCT00572481 is a clinical study titled "Axillary Reverse Mapping". We hypothesize that variations in anatomic location of the arm lymphatic drainage system put the arm lymphatics at risk for disruption during a SLNB and / or ALND. Therefore, mapping the drainage of the arm during the procedure would decrease the likelihood of inadvertent disruption of the lymphatic...
What is the current status of trial NCT00572481?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 1,000 participants. The study started on 2007-05. Estimated completion is 2027-11.
What conditions does trial NCT00572481 study?
This clinical trial studies the following conditions: Cancer of the Breast.
What interventions are being tested in trial NCT00572481?
The interventions under investigation include: Axillary Reverse Mapping (PROCEDURE).
Who is sponsoring clinical trial NCT00572481?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00572481 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of the Breast
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00572481's enrollment target sits among peer trials
1,000 1st of 15 higher than 15 of 15 other Cancer of the Breast trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer of the Breast trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
RECRUITING · Phase 2
-
Daance FOR Chemotherapy-induced Neuropathy
RECRUITING · Phase 2
-
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RECRUITING · Phase 2
-
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
RECRUITING · Phase 2
-
Proton Radiation for Stage II/III Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia